Roy Hantgan to Fibrinogens, Abnormal
This is a "connection" page, showing publications Roy Hantgan has written about Fibrinogens, Abnormal.
Connection Strength
0.154
-
Lounes KC, Lefkowitz JB, Henschen-Edman AH, Coates AI, Hantgan RR, Lord ST. The impaired polymerization of fibrinogen Longmont (Bbeta166Arg-->Cys) is not improved by removal of disulfide-linked dimers from a mixture of dimers and cysteine-linked monomers. Blood. 2001 Aug 01; 98(3):661-6.
Score: 0.044
-
Lounes KC, Lefkowitz JB, Coates AI, Hantgan RR, Henschen-Edman A, Lord ST. Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization. Ann N Y Acad Sci. 2001; 936:129-32.
Score: 0.042
-
Hogan KA, Gorkun OV, Lounes KC, Coates AI, Weisel JW, Hantgan RR, Lord ST. Recombinant fibrinogen Vlissingen/Frankfurt IV. The deletion of residues 319 and 320 from the gamma chain of firbinogen alters calcium binding, fibrin polymerization, cross-linking, and platelet aggregation. J Biol Chem. 2000 Jun 09; 275(23):17778-85.
Score: 0.041
-
Webb CD, Hantgan RR, Byeff PD, Owen J. Fibrinogen New Britain: characterization of an A alpha Arg 16-->His variant human fibrinogen. Blood Coagul Fibrinolysis. 1994 Apr; 5(2):233-8.
Score: 0.027